Follow the people · Insider

JV

Jason Coloma V

Insider · Chief Executive Officer · MAZE

Jason Coloma V files insider transactions with the SEC as a chief executive officer of Maze Therapeutics (MAZE). We hold 11 disclosed purchases and sales filed since 10 June 2016, 7 of them in the last 90 days.

  • Files forMAZE
  • Disclosed buys and sells11 in all, 7 in the last 90 days
  • Last disclosure4 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 22 September 20253 September 2026Chief Executive Officer · Maze Therapeutics (MAZE)30 Form 4 lines · source: SEC Form 4
  • Filed 8 June 20168 June 2016SVP, Chief Business Officer · Corvus Pharmaceuticals (CRVS)1 Form 4 line · source: SEC Form 4

Everything they disclosed

31 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.